Khaled A M Abouzid Selected Research

Protein Kinases (Protein Kinase)

11/2015

Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khaled A M Abouzid Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 04/2014
6	Breast Neoplasms (Breast Cancer) 02/2023 - 12/2020
3	Carcinoma (Carcinomatosis) 03/2019 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 05/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023
1	Leukemia 06/2023
1	Melanoma (Melanoma, Malignant) 06/2023
1	Kidney Neoplasms (Kidney Cancer) 06/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Necrosis 12/2021
1	COVID-19 08/2021
1	Inflammation (Inflammations) 12/2020
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 08/2020
1	Carcinogenesis 04/2020
1	Infections 01/2020
1	Adenocarcinoma 03/2019
1	Ascites 01/2018

Drug/Important Bio-Agent (IBA)

7	pyrimidineIBA 06/2023 - 01/2018
6	Phosphotransferases (Kinase)IBA 12/2022 - 04/2014
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2019 - 04/2016
4	EnzymesIBA 01/2022 - 03/2019
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 08/2016
3	Gefitinib (Iressa)FDA Link 11/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2022
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 04/2022
2	HexosesIBA 02/2023 - 04/2022
2	FructoseIBA 02/2023 - 04/2022
2	benzimidazoleIBA 12/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 12/2022 - 11/2017
2	Tamoxifen FDA LinkGeneric 01/2022 - 12/2020
2	Histone Deacetylase InhibitorsIBA 12/2021 - 01/2018
2	Caspase 3 (Caspase-3)IBA 08/2020 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 04/2020 - 11/2019
2	human ERBB2 proteinIBA 01/2018 - 11/2016
1	KetonesIBA 03/2024
1	Protein Isoforms (Isoforms)IBA 01/2024
1	PiperazineIBA 06/2023
1	acetamideIBA 06/2023
1	Monosaccharide Transport ProteinsIBA 02/2023
1	LipidsIBA 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022
1	BenzimidazolesIBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	6-deoxy-6-fluoro-D-fructoseIBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	Membrane Transport Proteins (Biological Pump)IBA 04/2022
1	ChalconesIBA 03/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022
1	SolutionsIBA 01/2022
1	4-nitrophenylIBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Histones (Histone)IBA 12/2021
1	indolin-2-oneIBA 12/2021
1	thienopyrimidineIBA 12/2021
1	Hydroxamic Acids (Hydroxamic Acid)IBA 12/2021
1	Aurora Kinase BIBA 12/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2020
1	Dinoprostone (PGE2)FDA Link 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Annexin A5IBA 08/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2020
1	isothiocyanic acidIBA 08/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	amuvatinibIBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	PyrimidinesIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2019
1	LigandsIBA 11/2019
1	QuinoxalinesIBA 03/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	AntioxidantsIBA 09/2018
1	pyrrolopyrimidineIBA 09/2018
1	Lapatinib (GW572016)FDA Link 07/2018
1	osimertinibIBA 12/2017
1	Anti-Infective Agents (Microbicides)IBA 11/2017
1	ElementsIBA 11/2017
1	Phosphodiesterase InhibitorsIBA 11/2017
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 07/2017
1	Adenosine Triphosphate (ATP)IBA 08/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	Adenosine Monophosphate (AMP)IBA 11/2015
1	BenzenesulfonamidesIBA 11/2015
1	TensinsIBA 11/2015
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2015
1	CurcuminIBA 07/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2014
1	anilinoquinazolineIBA 04/2014
1	EstersIBA 05/2013

Therapy/Procedure

8	Therapeutics 12/2022 - 12/2017
1	Drug Therapy (Chemotherapy) 12/2020
1	Oral Administration 11/2019